BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

138 related articles for article (PubMed ID: 34275378)

  • 1. The CHA2DS2-VASc Risk Score Predicts Total Occlusion in Infarct-Related Arteries in Patients With Non-ST Elevation Myocardial Infarction.
    Yaşar E; Bayramoğlu A; Karakuş Y; Çakmak T
    Angiology; 2022 Apr; 73(4):380-386. PubMed ID: 34275378
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prognostic value of CHA2DS2-VASc score in predicting high SYNTAX score and in-hospital mortality for non-ST elevation myocardial infarction in patients without atrial fibrillation.
    Akboğa MK; Yılmaz S; Yalçın R
    Anatol J Cardiol; 2021 Nov; 25(11):789-795. PubMed ID: 34734812
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Predictive accuracy of CHA
    Satılmış S; Durmuş G
    Acta Cardiol; 2021 Apr; 76(2):140-146. PubMed ID: 31900050
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Study on the predictive ability of emergency CHADS
    Huang X; Lv H; Liu Z; Liu Y; Yang X
    J Thorac Dis; 2022 Jul; 14(7):2611-2620. PubMed ID: 35928606
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Combining clinical predictors to better predict for the no-reflow phenomenon.
    Avci E; Yildirim T; Aydin G; Kiris T; Dolapoglu A; Kadi H; Safak O; Bayata S
    Eur Rev Med Pharmacol Sci; 2018 Aug; 22(15):4987-4994. PubMed ID: 30070335
    [TBL] [Abstract][Full Text] [Related]  

  • 6. CHA2DS2-VASc-HS score in non-ST elevation acute coronary syndrome patients: assessment of coronary artery disease severity and complexity and comparison to other scoring systems in the prediction of in-hospital major adverse cardiovascular events.
    Taşolar H; Çetin M; Ballı M; Bayramoğlu A; Otlu YÖ; Türkmen S; Aktürk E
    Anatol J Cardiol; 2016 Oct; 16(10):742-748. PubMed ID: 27025198
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Coronary artery disease severity and risk stratification of patients with non ST-elevation acute coronary syndrome using CHA
    Abdelmegid MAF; Hanna MEF; Demitry SR; Abdelhafez MAH
    BMC Cardiovasc Disord; 2024 May; 24(1):263. PubMed ID: 38773382
    [TBL] [Abstract][Full Text] [Related]  

  • 8. New CHA
    Zhang QY; Ma SM; Sun JY
    BMC Cardiovasc Disord; 2020 Jul; 20(1):346. PubMed ID: 32711475
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Usefulness of the CHA
    Peng H; Sun Z; Chen H; Zhang Y; Ding X; Zhao XQ; Li H
    Am J Cardiol; 2019 Aug; 124(4):476-484. PubMed ID: 31235063
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Association of CHA
    Maden O; Çakmak Karaaslan Ö; Kanal Y; Yakut İ; Yaman NM; Könte HC; Balcı KG; Selçuk MT; Selçuk H
    Herz; 2022 Oct; 47(5):456-464. PubMed ID: 34608522
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Risk evaluation of new-onset atrial fibrillation complicating ST-segment elevation myocardial infarction: a comparison between GRACE and CHA
    Luo J; Dai L; Li J; Zhao J; Li Z; Qin X; Li H; Liu B; Wei Y
    Clin Interv Aging; 2018; 13():1099-1109. PubMed ID: 29922048
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Predictive value of CHA2DS2-VASc score combined with hs-CRP for new-onset atrial fibrillation in elderly patients with acute myocardial infarction.
    Fu Y; Pan Y; Gao Y; Yang X; Chen M
    BMC Cardiovasc Disord; 2021 Apr; 21(1):175. PubMed ID: 33849448
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Predictive value of CHA2DS2-VASc and CHA2DS2-VASc-HS scores for failed reperfusion after thrombolytic therapy in patients with ST-segment elevation myocardial infarction.
    Kilic S; Kocabas U; Can LH; Yavuzgil O; Çetin M; Zoghi M
    Cardiol J; 2019; 26(2):169-175. PubMed ID: 29512096
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Value of CHA2DS2-VASc Score for Prediction and Ruling Out of Acute Stent Thrombosis After Primary Percutaneous Coronary Intervention.
    Açikgöz SK; Açikgöz E; Çiçek G
    Angiology; 2020 May; 71(5):411-416. PubMed ID: 32030991
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The CHA2DS2-VASc Risk Score Predicts Total Occlusion in Infarct-Related Arteries in Patients With NSTEMI: Reply.
    Yaşar E; Bayramoğlu A; Karakuş Y; Çakmak T
    Angiology; 2022; 73(10):987. PubMed ID: 34607489
    [No Abstract]   [Full Text] [Related]  

  • 16. CHA2DS2-VASc score is useful in predicting poor 12-month outcomes following myocardial infarction in diabetic patients without atrial fibrillation.
    Hudzik B; Szkodziński J; Hawranek M; Lekston A; Poloński L; Gąsior M
    Acta Diabetol; 2016 Oct; 53(5):807-15. PubMed ID: 27339195
    [TBL] [Abstract][Full Text] [Related]  

  • 17. CHA2DS2-VASC Score Predicts Risk of Contrast-Induced Nephropathy in Non-ST Elevation Myocardial Infarction Patients Undergoing Percutaneous Coronary Interventions.
    Baydar O; Kilic A
    Kidney Dis (Basel); 2019 Oct; 5(4):266-271. PubMed ID: 31768384
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Predictive value of CHADS
    Li X; Zeng Z; Yang X; Wang H
    BMC Cardiovasc Disord; 2021 Sep; 21(1):439. PubMed ID: 34525958
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [The predictive value of the CHA
    Qing P; Yang YM; Hu LT; Yu W; Xu LL; Wang N; Suo N
    Zhonghua Nei Ke Za Zhi; 2022 Feb; 61(2):177-184. PubMed ID: 35090253
    [No Abstract]   [Full Text] [Related]  

  • 20. CHA2DS2-VASc Score as an Independent Predictor of Suboptimal Reperfusion and Short-Term Mortality after Primary PCI in Patients with Acute ST Segment Elevation Myocardial Infarction.
    Ashoori A; Pourhosseini H; Ghodsi S; Salarifar M; Nematipour E; Alidoosti M; Haji-Zeinali AM; Nozari Y; Amirzadegan A; Aghajani H; Jalali A; Hosseini Z; Jenab Y; Geraiely B; Omidi N
    Medicina (Kaunas); 2019 Feb; 55(2):. PubMed ID: 30717292
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.